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Abstract
Despite the known propensity of small-molecule electrophiles to react with numerous cysteine-
active proteins, biological actions of individual signal inducers have emerged to be chemotype-
specific. To pinpoint and quantify the impacts of modifying one target out of the whole proteome, 
we develop a target-protein-personalized “electrophile toolbox” with which specific intracellular 
targets can be selectively modified at a precise time by specific reactive signals. This general 
methodology—T-REX (targetable reactive electrophiles & oxidants)—is established by: (1) 
constructing a platform that can deliver a range of electronic and sterically different bioactive 
lipid-derived signaling electrophiles to specific proteins in cells; (2) probing the kinetics of 
targeted delivery concept which revealed that targeting efficiency in cells is largely driven by 
initial on-rate of alkylation; and (3) evaluating the consequences of protein-target- and small-
molecule-signal-specific modifications on the strength of downstream signaling. These data show 
that T-REX allows quantitative interrogations into the extent to which the Nrf2 transcription 
factor-dependent antioxidant response element (ARE) signaling is activated by selective 
electrophilic modifications on Keap1 protein—one of several redox-sensitive regulators of the 
Nrf2–ARE axis. The results document Keap1 as a promiscuous electrophile-responsive sensor 
able to respond with similar efficiencies to discrete electrophilic signals, promoting comparable 
strength of Nrf2–ARE induction. T-REX is also able to elicit cell activation in cases in which 
whole-cell electrophile flooding fails to stimulate ARE induction prior to causing cytotoxicity. 
The platform presents a previously unavailable opportunity to elucidate the functional 
consequences of small-molecule-signal- and protein-target-specific electrophilic modifications in 
an otherwise unaffected cellular background.
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Lipid-derived electrophiles (LDEs) are a diverse class of endogenous small molecules 
capable of covalently modifying proteins.1 The LDE-derived post-translational 
modifications have shown growing importance in regulating redox-dependent intracellular 
communications.1,2 The biological consequences of LDE-derived protein modifications are 
most associated with a wide range of cytoprotective signaling responses.1-3 However, unlike 
conventional enzyme-assisted modifications such as phosphosignaling,2 much less is known 
about the mechanisms by which diffusible small-molecule chemical messengers non-
enzymatically orchestrate signal susceptibility of specific proteins in a cell or modulate the 
strength of signal propagation downstream.1,3 Essentially an innumerable array of 
chemically diverse LDEs is available. However, how a specific protein target/pathway deals 
with reactive LDEs, and whether timing and specificity differ across various LDE classes 
remain unclear.3
Individual LDE signaling events have traditionally been studied by “overload” 
methodologies in which cells are swamped with reactive signal-inducers and a particular 
response is read out. However, when the entire cell is exposed to a reactive signal, numerous 
proteins [> 700 in the case of a well-known signaling electrophile 4-hydroxynonenal 
(HNE)]4a are modified simultaneously. Thus, precise information linking varied chemical 
architectures of LDE signals and/or timing of modifications to phenotypic responses 
triggered by modifying specific protein targets in a cell is not easily attainable.1,3,4 Recent 
innovations in quantitative proteomics involving global treatment with signaling 
electrophiles have provided powerful insights into relative cysteine (Cys) reactivity within 
the human proteome.4 However, even these innovative approaches can only rank 
reactivities, and lack the ability to perturb specific proteins or forge a link between specific 
target modification by individual LDEs and specific response downstream.
In addition to the physiologic relevance of endogenous LDE modifications in redox-linked 
cell signaling,1,3,4 small-molecule drugs with electrophilic motifs analogous to those 
manifested in LDEs are also increasingly recognized for pharmacologic benefits.5 
Importantly, existing data in the field of LDE signaling show evidence of distinct biological 
specificity and responses elicited by myriad LDEs featuring chemical structural resemblance 
of varying degrees.6 To date however, the mechanisms by which chemically discrete small-
molecule redox-mediators establish their phenotypic bioreactivity on a single protein target 
at a given instant in cells, and how these modest modifications on specific targets in turn 
influence the magnitude of downstream signaling, remains shrouded in mystery1,3,4-7(Figure 
1a).
Michael acceptors, such as endogenous LDEs1b,3,4,6 and cyclopentenone prostaglandin 
metabolites,1a,3a,8 constitute an important class of small-molecule electrophilic inducers for 
the transcription factor “nuclear factor-erythroid 2 p45-related factor 2” (Nrf2)-regulated 
“antioxidant response element” (ARE)-driven genes.3a,9 However, the regulatory 
mechanisms of Nrf2–ARE signaling axis are multimodal9a—many of the upstream 
pathways are mediated by proteins that are reportedly redox-sensitive (Figure 2, inset).10 As 
a cytosolic anchor of Nrf2 and an adaptor protein for Cul3-based ubiquitin E3 ligase 
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complex for Nrf2, the “Kelch-like ECH-associating protein 1” (Keap1)11 helps to maintain a 
low steady-state level of Nrf2 by constitutively ushering Nrf2 to be degraded by the 
proteasome.10,11 Whole-cell electrophile flooding results in blockage of Nrf2 degradation 
and consequent ARE upregulation.9-11 Since Keap1 is a highly cysteine rich protein—well 
known in vitro to form covalent adducts with myriad electrophiles including LDEs, the 
Nrf2–ARE activation observed subsequent to whole-cell electrophile treatment is in part 
attributed to Keap1 operating as a redox-dependent ARE-regulator through direct interaction 
with small-molecule electrophiles.11 However, multiple Keap1-independent electrophile-
responsive mechanisms of Nrf2–ARE regulation are known.9-11 Many upstream regulators 
of Nrf2–ARE axis (Figure 2, inset) are also shown to covalently bind LDEs such as 4-
hydroxynonenal (HNE).10,11e Developing a quantitative understanding of the Nrf2–ARE 
pathway has recently proven attractive with the emergence of electrophilic drugs such as 
BG-12 (Tecfidera) that are thought to function in part through activation of ARE response 
by Keap1 alkylation.5a-b
We recently communicated a proof of concept demonstrating selective delivery of the most 
well-studied LDE, HNE(alkyne) 1 (Scheme S1), to redox-active proteins in live mammalian 
cells at a precise time.12 We subsequently extended this method to interrogate whether 
specific HNEylation of Keap1 in low stoichiometry could elicit an ARE response, or 
whether subsidiary factors were required.13 These pilot studies unambiguously demonstrated 
that Keap1 is a key redox sensor along the Nrf2–ARE cascade—specifically, HNEylation of 
Keap1 is alone biologically sufficient to elicit an ARE response of magnitude similar to that 
observed under whole-cell HNE flooding.13 Thus, T-REX allows quantitation of the relative 
strength of downstream signaling selectively induced by Keap1-alone HNEylation—
information not easily obtainable by whole-cell LDE treatment approaches.1,3-7 Notably 
however, widely different biologic responses are reportedly elicited by whole-cell 
stimulation with structurally different LDEs.6 Unfortunately, diffferent chemical properties 
of each individual LDE also result in hitting different sets of targets beyond Keap1, thereby 
giving rise to different off-target responses. Thus, achieving a new ability to precisely 
correlate single-LDE-signal-specific targeted perturbations to specific biological responses 
of interest is important. Our attention thus turned to generalization of the T-REX strategy to 
a broad array of lipid-derived signaling electrophiles. We thus not only set out to 
quantitatively understand the tolerance, scope, and mechanistic basis of the unique T-REX 
tool, but also sought to transform this newly developed concept into a generalizable platform 
with which we can quantitate the magnitude of signaling response that can be activated by 
specific chemical signals selectively delivered to specific proteins in living cells (Figure 1a).
Despite the apparently privileged role of Keap1 in reactive small-molecule sensing,11 the 
functional relationship between electrophilicity/structural variations within small-molecule 
Michael acceptors and potency of ARE induction downstream remains largely unclear. 
There is currently no coherent view of the structure–activity relationship of reactive 
electrophiles and specific biological responses—such as ARE regulation—through precise 
target modifications in the literature. Indeed it has been challenging to precisely address this 
issue because ARE induction depends on a number of variables—including cell 
permeability, protein target promiscuity, stability, and toxicity of discrete small-molecule 
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signals—beyond their ability to modify Keap1 (and other known redox-sensitive regulators 
of the Nrf2–ARE axis10,11e). Some reports implicate that a range of structurally similar 
small-molecule electrophilic entities all elicit similar levels of ARE induction, and hence 
Keap1 has evolved to be a promiscuous sensor in responding to myriad structurally discrete 
inducers.14 On the other hand, ranges as large as ~50–1000-fold differences in the 
downstream gene activation potencies have been implicated across structurally similar enal- 
and enone-based inducers,5e,15 possibly suggesting that Keap1 is a more discerning sensor 
of electrophiles. However, since all these data were collected using global electrophile 
stimulation, a condition in which multiple redox-sensitive ARE-regulators are modified by 
the reactive signals,4,10 the ultimate phenotypic ARE response is less likely to be a true 
representative of signal- and target-specific ARE induction strength. T-REX is thus suited to 
parse out these outstanding complexities in the field. Herein we disclose the results of our 
interrogations into T-REX-assisted targeted delivery of reactive LDEs 1–10 (Figure 2) 
selectively to Keap1 with spatiotemporal regulation, and quantitative evaluations of how 
these signal- and target-specific modest modifications specifically translate to modulate the 
strength of Nrf2–ARE signal propagation.
RESULTS
Construction of T-REX Electrophile Toolbox
We first focused on alkenal-based linear Michael acceptors 2–7 (Figure 2) that have been 
implicated to regulate various cellular functions and cytoprotective responses.3a,6 The 
alkyne functionalization at the chain terminus enables tracking of proteins covalently bound 
(via HaloTag,16 Figure 1b) to the caged precursors, or quantitative assessment of the extent 
to which specific proteins are modified by the liberated electrophile (by using Click 
coupling17 with Cy5-azide).12 Photocaged precursors to alkyne-functionalized alkenals—
ONE 2, dHNE 3, HHE 4, HDE 5, HDDE 6, and 2-HD 7—(11–16, Figure 2) (Scheme S2–
S7) were selected. These alkenals not only regulate various physiologic responses3a,6 but 
they also cover a range of chain lengths and electronically diverse Michael acceptors 
allowing us to investigate the tolerance of T-REX.
Our initial synthetic strategy was centered upon extending the previously reported synthesis 
of Ht-Pre-HNE 1712 (Figure 3a). In this approach, Williamson ether synthesis18 furnishes 
the caged electrophile from anthraquinone 18 and allylic bromide 19—accessed from known 
aldehyde 20 and the corresponding Grignard reagent, or other simple precursors. Syntheses 
of HaloTag-targetable caged precursors: Ht-Pre-HNE 17, Ht-Pre-dHNE 12, Ht-Pre-HHE 13, 
Ht-Pre-HDE 14, Ht-Pre-HDDE 15, and Ht-Pre-2-HD 16 were successfully accomplished 
using this approach (Scheme S3–S7). Ht-Pre-ONE 11 was synthesized via allylic oxidation 
of 17 (Scheme S2).
We were also motivated to ultimately expand T-REX approach to delivering enones—both 
linear and cyclic (8–10, Figure 2). However, enones potentially represent a challenge 
because (1) they are less reactive than enals, and (2) the photo-uncaging method used in T-
REX has not been well established for liberating enones in aqueous media.12,19 
Cyclohexenone-derived systems serve as simplified representatives of electrophilic 
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pharmacophores such as oleanane-derived synthetic triterpenoids CDDOs,5c,d,20 whereas 
cyclopentenone-based delivery platforms can serve as simple models of isoprostanes and 
prostaglandins—an important class of endogenous signaling molecules.8,21 Keap1 is indeed 
a postulated cellular target of these enone-based Michael acceptors.20-21 Ht-Pre-DE 21, Ht-
Pre-CHE 22, and Ht-Pre-CPE 23 were thus constructed.
The synthesis of caged enones necessitated a new synthetic strategy because Williamson 
ether synthesis was found to be not efficient with secondary allylbromides. Williamson 
coupling is also not amenable to the synthesis of corresponding non-caged alkyne-
functionalized enones 8–10, analysis of which should prove useful for comparing the 
signaling impact of T-REX approach to that achieved from whole-cell electrophile soaking. 
We thus developed a more general method (Figure 3b) in which the caged electrophile was 
derived from anthraquione 18 and alcohol 24 via Mitsunobu reaction.22 Using this strategy, 
Ht-Pre-DE 21, Ht-Pre-CHE 22, and Ht-Pre-CPE 23 were prepared efficiently (Scheme S8–
S10). Compared to the previously reported Williamson coupling-based strategy,12 the new 
Mitsunobu-based approach provided simultaneous access to both caged and non-caged 
electrophiles. For instance, Ht-Pre-CHE 22 was constructed directly from silylated CHE 9 
(Scheme S9). On the other hand, Ht-Pre-CPE 23 was synthesized from the alcohol-
derivative of enone CPE 10, which was simpler to prepare than the enone itself (Scheme 
S10).
Assessment of Biocompatible Photouncaging Efficiency
We found that photouncaging caged precursors—11–17, and 21–23—covalently bound in 
1:1 stoichiometry to HaloTag in solution was an efficacious way to evaluate the kinetics of 
photoinduced LDE liberation. By using in-gel fluorescence analysis, the time-dependent 
Cy5 signal depletion was measured subsequent to photouncaging and Click coupling (Figure 
4 and S1). The release kinetics showed controlled rapid electrophile liberation of all enals 1–
6 at 37 °C (pH 7.6) (t½ < 1 min for most cases) (Table S1, Figure 4 and S1). The release of 
2-HD 7 under standard conditions was however inefficient (Figure S1e). But when the 
experiment was replicated under denaturing conditions in which HaloTag prebound with Ht-
Pre-2-HD 16 was treated with 1% SDS before photouncaging, a release rate (t½) of ~ 0.6 
min was measured for 2-HD 7 (Figure S1f)—a value similar to that of other enals 1–6 
(Table S1). This observation suggested that the long aliphatic chain within the liberated 2-
HD 7 (and/or within the “precursor 16–HaloTag” complex) non-specifically binds to 
HaloTag presumably through hydrophobic interactions,16 allowing covalent bond formation 
between HaloTag and 2-HD 7 to occur subsequent to photolibeartion of 7 from the caged 
precursor 16. Based off these findings, Ht-Pre-2-HD 16 was omitted from subsequent 
studies. On the other hand, all three enones studied 8–10 were liberated efficiently. The 
release of enone DE 8 from Ht-Pre-DE 21 was ~twice as fast (t½ ~ 0.3 min) as enals 1, 3–6 
from their corresponding precursors (17, 12–15), respectively (Table S1, Figure S1). The 
cyclic enones CHE 9 and CPE 10 were also liberated successfully (Table S1, Figure S1). 
These data collectively documented that HaloTag is largely unreactive to enals and enones, 
and thus serves as a good point source of electrophilic signals. Energy minimization analysis 
(Macromodel, Schrödinger Inc.) (Figure 1b) further showed that the 15-atom linker renders 
Lin et al. Page 5













the inert caged motif solvent-exposed, enabling release of the reactive signals to the 
surrounding microenvironment of the target protein fused to HaloTag.
Alkylation Rate Profiles
We developed T-REX on the premise that targeted delivery in cells enables rapid 
accumulation of liberated electrophile within the coordination sphere of the target protein. 
The redox-sensitive target and the reactive chemical entity thus constitute a solvent-caged 
“target–signal encounter complex23”. The liberated reactive particle was expected to 
partition between quasi-intramolecular interaction with the target, and diffusion away from 
the target protein to the bulk medium where it was expected to by scavenged by cellular 
thiols such as glutathione (GSH) present in mM quantities.24a Since the reactive small 
molecule can only be generated maximally in stoichiometry with respect to the target protein 
(Figure 1b), side reaction with proteins other than the target was expected to be low.24
We initially examined the alkylation rate profiles of purified recombinant human His6-
Keap1 (Table S2) protein with various LDEs of differing electrophilicity. The relative 
alkylation rates of Michael acceptors dHNE 3 and HNE 1 (Figure 2) were first compared. 
Precise determination of 2nd-order rates was not possible in this case because different sets 
of cysteine (Cys) residues on Keap1 reportedly interact with a given electrophile,9,11 and 
presumably do so at different rates.25 Under the conditions in which His6-Keap1 was 
directly treated with 1 equiv of reactive LDE of interest (Figure 5), the data with dHNE 3 
showed that it took ~twice as long for the Cy5-signal intensity on Keap1 to reach saturation 
compared to HNE 1. Notably however, the initial (< 10 min) rates of covalent adduction by 
3 and 1 were comparable. The less reactive enone CHE 9 was next examined under identical 
conditions. The reaction profile was overall clearly distinct from those of dHNE 3 and HNE 
1. Alkylation with CHE 9 required a ~4–5-fold longer time to reach Cy5-signal saturation on 
Keap1 (Figure 5b). However, the initial alkylation rate of CHE 9 was not significantly 
different from that of linear enals 1 or 3 (Figure 5b inset).
These data could be most simply explained by a two-step mechanism involving assembly of 
an encounter complex between Keap1 and the electrophile, followed by alkylation. In one 
possible mechanistic scheme (A), CHE 9 would have a lower affinity for Keap1 with respect 
to dHNE 3 which would have a lower affinity than HNE 1. An alternative mechanism (B) is 
that CHE 9 interacts with fewer cysteines (Cys’s) than dHNE 3 and HNE 1 during encounter 
complex formation. Thus, as alkylation progresses, the number of reactive sites on the 
protein is depleted, and hence the rate drops off. A hybrid of (A) and (B) also remains a 
possible mechanism.
Residue Availability and Specificity in Keap1 Alkylation
CHE 9 and HNE 1 featured distinct progress curves for their reactions with recombinant 
Keap1 in solution (Figure 5). As an initial step to probe the Keap1 Cys residue pools 
available to react with HNE 1 and CHE 9, LC-MS/MS analysis was performed. Subsequent 
to direct treatment of recombinant Halo-Keap1 with 1 equiv of CHE 9, LC-MS/MS analysis 
showed CHE-derived modifications on 2 Cys residues—C151 and C288, with respective 
Mascot ion scores (IS) of 48 and 36 (Table S3). Substituting HNE 1 in place of CHE 9 and 
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replication of the experiment revealed 6 HNEylated residues instead—C77, C151, C226, 
C273, C319 and C368—with IS’s: 60, 74, 54, 61, 40 and 95, respectively.13 The increased 
promiscuity of HNE relative to CHE thus most likely accounts for the differences in overall 
alkylation rate seen in the progress curves above (Figure 5b). In addition, C151 was 
identified as an overlap between the two sets of Cys residues characterized to be modified 
during CHE- as well as HNE-adduction events. It is worth noting that all these Cys residues 
are implicated in Keap1 electrophile response.11e
We also progressed to investigate whether T-REX vs. non-targeted delivery shared similar 
Cys alkylation patterns on Keap1 with the use of respective caged precursors Ht-Pre-CHE 
22 and Ht-Pre-HNE 17. Under T-REX conditions in which the recombinant Halo-Keap1 in 
solution was targeted by CHE 9 using 1 equiv of Ht-PreCHE 22 and subsequent light 
exposure, C151 of Keap1 was the only residue modified (IS, 50) (Table S4 and S5). On the 
other hand, T-REX-targeted HNEylation with Ht-Pre-HNE 17 under identical conditions 
yielded 2 Cys residues HNEylated—C226 and C368 (IS, 51 and 61, respectively).13 These 
data further corroborated the hypothesis of a lower number of Cys residues available for 
CHE 9 over HNE 1.
T-REX Delivery in Cells
Upon the basis of the in vitro kinetic data, the caged precursors to LDEs constructed in our 
toolbox, including enones housing reduced intrinsic electrophilicity (Figure 2), should 
efficiently alkylate Keap1 in cells, provided the postulated encounter complex mechanism is 
operative. T-REX delivery was performed in HEK-293 cells stably expressing Halo-Keap1 
fusion protein (Figure 6 and S2). The percentage delivery efficiency in cells was determined 
using Eq. 1 in which superscript “x” designates sample exposed to both light and TEV 
protease. Superscript “y” designates sample not treated with light or TEV. Briefly, the 
method involved quantitating the amount of Cy5 signal on Keap1 (post photoactivation and 
TEV-protease-catalyzed separation of Halo and Keap1 domains subsequent to cell lysis and 
Click coupling), relative to the signal on Halo-Keap1 in the sample not exposed to light and 
TEV. Western blot (WB) of Keap1 validated equal protein levels (see Eq. 1 and also Figure 
S2 legend). The remaining Cy5 signal on Halo, post TEV cleavage, results from incomplete 
release of the reactive electrophile from the cage—presumably due to lower photouncaging 
efficiency in cells.
The remaining signal on Halo band was accounted for in quantitating the delivery efficiency 
as shown in Eq. 1.
(Eq. 1)
We observed that ONE 2 was ineffective because the caged precursor Ht-Pre-ONE 11 itself 
covalently conjugated to cellular proteins non-specifically prior to photoliberation (Table 1, 
entry 2, and Figure 6b). This finding can be explained because Ht-Pre-ONE 11 itself harbors 
a reactive Michael acceptor enone moiety. This observation also underscores the fact that 
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multiple target modifications are unavoidable from whole-cell soaking with highly reactive 
enals and enones such as HNE and ONE.4 It is worth noting that despite overexpressing 
Halo-Keap1 in these cells, Halo-Keap1 did not even represent one of the bands displaying 
strongest Cy5 intensity (Figure 6b).
On the other hand, temporally controlled targeting of enals 2–5 to Keap1 was successful 
(Table 1, Figure 6a and S2) as in the previous proof-of-concept targeting of 1 to specific 
proteins in cells.12 Within our limit of detection, the delivery was target-specific—a result in 
stark contrast to whole-cell electrophile flooding (Figure 6b and Ref. 4). Among all linear 
alkenals delivered (Table 1, entry 2–6), the electrophiles bearing a 4-hydroxy group (4 and 
5) gave a slightly higher targeting (~30%) than the less electrophilic 4-dehydroxy-analog, 
dHNE 3 (21%), indicating that reactivity can play a part in dictating delivery efficiency, but 
it is not largely significant.
The length of the carbon chain did not appear to significantly impede the reactivity with 
Keap1 in cells since Ht-Pre-HHE 13 and Ht-Pre-HDE 14 provided similar levels of Keap1-
targeted alkylation efficiency. The issue associated with the release of 16-carbon chain 2-
HD 7 from 16 was discussed above (Figure S1). The delivery with Ht-Pre-HDDE 15 
however failed. We speculated that the unsuccessful T-REX-targeted delivery of HDDE 6 is 
likely due to intramolecular photoinduced side reaction between the cis-alkene at C6–C7 
and the terminal alkyne, thereby destroying the reporter alkyne unit.26 This proposal was 
supported by 29% delivery efficiency attainable with HDE 5 that has no C6–C7 alkene but 
is otherwise identical to HDDE 6.
The delivery efficiency of linear enones was next investigated. The targeted delivery 
efficiency of DE 8 in cells using Ht-Pre-DE 21 gave 22% delivery, indicating that Keap1 is 
also susceptible to linear enones, with delivery efficiency similar to that of 4-dehydroxylated 
enal dHNE 3 (Table 1, entry 3 and 8). Directed alkylation with cyclic electrophile CHE 9 
(derived from photouncaging of Ht-Pre-CHE 22) resulted in 25% delivery efficiency. The 
delivery efficiency was in the same range as linear enals 1–5 and enone DE 8 (Table 1). Ht-
Pre-CPE 23 that models simple cyclopentenones was also tested in cells. The 19% delivery 
efficiency for CPE 10 was on par with that of dHNE 3 and DE 8 (Figure 7 and S2). These 
data collectively imply that T-REX is a functional platform for selectively perturbing an 
intracellular signaling target with electronically disparate bioactive electrophiles. The 
similar levels of delivery efficiencies across all the small-molecule inducers tested show that 
T-REX has a broad substrate delivery scope that will enable quantitative profiling of many 
small-molecule electrophiles in the future, with target-specificity as well as temporal 
control.
T-REX Delivery Mechanism in Cells
We next proceeded to investigate the delivery mechanism of T-REX in live cells. Our 
current model predicts that fusion of the HaloTag to the target protein is required for T-REX 
delivery to occur. To test this postulate, two separate expression vectors encoding the two 
fusion genes—GFP-Halo and GFP-Keap1—were used to coexpress Halo and Keap1 
separately in HEK-293 cells. These cells were subjected to T-REX conditions using Ht-Pre-
Lin et al. Page 8













DE 21 as an example (Figure 7). This condition showed no Cy5 signal on Keap1. 
Replicating these experiments with non-GFP-tagged constructs, i.e, co-expression of Halo 
protein and Keap1 proteins, also resulted in identical outcomes (Figure S3). Importantly, no 
background protein reactivity was observed either, indicating that non-specific protein 
targeting is minimal under T-REX conditions, even when no target protein fused to HaloTag 
bearing the caged precursor is available. On the other hand, as we disclosed above (Figure 
S2c and Table 1), alkylation of Keap1 by DE 8 was reproducibly observed in the positive 
control experiment in which HaloTag was fused to Keap1 (Figure 7). We further validated 
this proximity-induced targeting concept by comparing the delivery efficiency of T-REX 
using Ht-Pre-HNE 17 in a system in which Halo and Keap1 were co-expressed separately, to 
that in which Halo and Keap1 were fused but otherwise performed under identical 
conditions. Keap1 failed to be effectively alkylated by HNE 1 when the HaloTag was 
expressed as a separate protein in cells (Figure S4). These data altogether support the 
directed alkylation model within the target–signal encounter complex. The proximity-
induced targeted delivery model was further validated by the results from pathway 
activation studies described in the following sections.
Quantitating Relative Downstream Signaling Strength—the Degree of Nrf2 Stabilization
Our recent data show that Keap1-specific substoichiometric (~34%) HNEylation enabled by 
T-REX is sufficient to induce downstream response—blocking of Nrf2 proteasomal 
degradation and upregulation of ARE.13 We here examined the extent to which modest 
chemical perturbations across the various LDE signals delivered selectively to Keap1 in 
cells modulate the relative levels of Nrf2–ARE activation. We accomplished this goal using 
two independent quantitative readouts: (1) western blot analysis probing the upregulation of 
Nrf2 steady-state levels, and (2) reporter gene assay quantitating the fold increment of ARE-
driven firefly luciferase signal, normalized over constitutively expressed Renilla luciferase 
(Figure 8).
HEK-293 cells expressing Halo-Keap1 and Nrf2 were treated with the designated caged 
precursor. As a proof-of-concept comparison, Ht-Pre-HNE 17, Ht-Pre-dHNE 12, Ht-Pre-DE 
21, Ht-Pre-CHE 22, and Ht-Pre-CPE 23 were chosen because they reflect delivery of 
electronically as well as sterically discriminated electrophiles (long-chain enals HNE 1 and 
dHNE 3, and cyclic/acyclic enones DE 8, CHE 9, and CPE 10). As described above, the 
targeted delivery efficiencies to Keap1 quantitated using in-gel fluorescence analysis 
subsequent to Click coupling assays were comparable across the majority of these 
electrophiles—dHNE 3, DE 8, CHE 9, and CPE 10 (19–25%), except ~33% for HNE 1 
(Table 1 and Figure 6 and S2). Should Keap1 alkylation event determine the fate of 
downstream signaling, a similar extent of downstream signaling strength should be 
achievable. On the other hand, should Keap1 sense not only electrophile adduction, but also 
some aspect of the individual LDE signal, differing levels of ARE signaling would be 
expected depending on the LDE employed.
The degree of Nrf2 stabilization was first interrogated. Western blot analysis showed similar 
levels of upregulation (~2–3 fold) of Nrf2 protein expression across the representative 
electrophiles (Figure 9a and S5). Light-alone or caged-precursor-alone treatment did not 
Lin et al. Page 9













lead to statistically significant Nrf2 stabilization (Figure 9c). As a comparison, we also 
analyzed the extent of phenotypic Nrf2 stabilization induced upon global electrophile 
stimulation. 25 μM LDE was selected as the concentration of choice at which significant 
downstream response (assessed by ARE activation, Figure S6, vide infra) was attained while 
maintaining ~80–90 % of cell viability (assessed by alamarBlue assay) (Figure S7). The 
western blot analysis showed that under identical incubation time and conditions, whole-cell 
electrophile incubation, using dHNE 3, DE 8, or CHE 9, led to a similar degree of Nrf2 
stabilization (Figure 9b and S5). Interestingly, the data showed the direct treatment of 
cyclopentenone CPE 10 did not result in Nrf2 stabilization. The basis behind this interesting 
distinction between T-REX-assisted targeted CPE delivery and whole-cell CPE 10 treatment 
is probed in the next section.
Quantitating Relative Downstream Signaling Strength—the Degree of ARE Upregulation
The magnitude of Nrf2-dependent ARE induction was next interrogated in HEK-293 cells 
ectopically expressing ARE-inducible firefly and constitutive Renilla luciferases alongside 
Halo-Keap1 and Nrf2 (Figure 10). The same set of caged precursors—Ht-Pre-HNE 17, Ht-
Pre-dHNE 12, Ht-Pre-DE 21, Ht-Pre-CHE 22, and Ht-Pre-CPE 23—used in evaluating the 
Nrf2 stabilization (Figure 9 and S5) was analyzed in evaluating ARE activation. Consistent 
with the similar delivery efficiency to Keap1, a comparable (~1.5–3-fold) enhancement of 
downstream ARE response was measured for each LDE with respect to vehicle controls 
(Figure 10b). The caged precursor alone or light alone controls showed no significant ARE 
upregulation. The relatively higher fold increase in ARE induction from Ht-Pre-HNE 17 and 
Ht-Pre-CHE 22 may be correlated with their delivery efficiencies to Keap1 lying at the 
higher end, ~33% and ~25%, respectively (Table 1, and Figure 6 and S2).
As with Nrf2 stabilization readout (Figure 9 and S5), we also analyzed the impact on ARE 
upregulation from whole-cell electrophile stimulation. Titration studies first showed that 25 
μM LDE in these studies provided near-maximal levels of ARE induction (Figure S6) 
without compromising viability assessed at 18 h post treatment (Figure S7). As with our 
previous finding on HNEylation,13 the level of ARE response from T-REX-targeted 
approach largely phenocopied that attainable from whole-cell treatment for all cases except 
CPE 10. With global treatment of CPE 10, we failed to observe both Nrf2 stabilization and 
ARE upregulation (Figure 9b–c and S5b–c), although CPE 10 is still able to deplete cell 
viability in a dose-dependent manner (Figure S7). At 25 μM, it is also able to penetrate cells 
and alkylate Keap1 within 1 h treatment (Figure S9) despite no measurable ARE 
upregulation. On the other hand, targeted approach clearly resulted in downstream signal 
amplification using both types of readouts (Figure 9, 10 and S5). To delve deeper into 
possible reasons behind the lack of ARE response from global CPE 10 stimulation under 
non-cytotoxic conditions, dose-dependent titration was peformed including an earlier time 
point (4 h) (Figure S10a). Although at 18 h time point, the ARE response failed to activate 
until cytotoxic concentrations of CPE 10 were applied (viability EC50 ~ 103 μM, Figure S7), 
the ARE response was observable at the earlier (4 h) time point, albeit to a limited level. 
With the T-REX method that delivers CPE 10 specifically to Keap1 alone, strong ARE 
activation was achieved at 18 h post modification (Figure S10b). The time dependent off-
target mixed responses stemming from whole-cell covalent modification by CPE 10 that 
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accumulate during the multi-hit scenario may in part explain this interesting observation. 
The off-target spectra also likely differ among individual LDEs. T-REX-targeted approach 
may thus prove useful for promoting downstream signal amplification by its ability to 
perform precision targeting.
Blocking Pathway Activation in Applying T-REX on the Non-HaloTag-fused System
Since we had shown that Keap1-specific targeting required the HaloTag to be genetically 
fused to Keap1, we postulated that if Halo and Keap1 were expressed separately [in which 
no LDE targeting occured to Keap1 (Figure 7, S3, and S4)], no increase in Nrf2 steady-state 
levels would be observed under T-REX conditions. Consistent with this expectation, when 
HaloTag and Keap1 were co-overexpressed as two seperate proteins, Nrf2 stabilization was 
abolished upon applying T-REX using Ht-Pre-HNE 17 and Ht-Pre-DE 21, respectively 
(Figure S8). These results strongly imply that Nrf2 upregulation we observe under T-REX 
targeting with Halo-Keap1 (Figure 9 and S5) is solely due to Keap1-targeted modification. 
Moreover, since ARE activation occurs due to modification of sensor proteins (including 
Keap1), the lack of AR upregulation in the case where T-REX is performed in the system in 
which Halo and Keap1 are expressed separately13 confirms our postulate that T-REX 
conditions do not perturb the cell.
Functional Redundancy of Cys Residues in Keap1-specific Electrophilic Regulation
Our recent data with T-REX-assisted Keap1-targeted HNEylation in HEK-293 cells argue 
against the existence of obligatory Cys residues among the 27 Cys residues of human Keap1 
protein that must be HNEylated to trigger pathway activation. To evaluate the extent to 
which residue specificity plays a general role in Keap1-specific electrophilic regulation, we 
identified Cys residues modified subsequent to treatment with CHE 9 either globally (25 
μM, 20 min) or by using Ht-Pre-CHE 22 under T-REX conditions (Table S6 and S7). 
TALON enrichment of Halo-Keap1 protein from treated cells under native conditions, and 
subsequent trypsin digestion and LC-MS/MS analysis, revealed C613 (23, 0.005) and C489 
(13, 0.05) as sites modified under T-REX conditions. The two numbers in parentheses 
designate Mascot ion scores and p-values, respectively. Because the Mascot scoring depends 
on the size of database used for the search and in our case the protein identity was known for 
Keap1 which we purified from HEK-293 cells, the low scores were expected. However, 
across all samples—either T-REX or global treatment, we set the Mascot ion score threshold 
to be the same with the p value of ≤ 0.05 (see supporting information method section for 
details). This setting precluded the possibility of overlooking such low-score residues in 
other data sets. In our opinion, modification at C489 should be regarded as a low-confidence 
score with p value of 0.05. This modification was thus not further considered in subsequent 
sections unless otherwise stated.
On the other hand, under whole-cell CHE 9 treatment, C513/C518 [75, (3.2 × 10−8)], and 
C273 [52, (6 × 10−6)] were modified. The numbers in square brackets represent Mascot ion 
scores and p values, respectively. Based on the site analysis results of Mascot search, the 
chances of modification on C513 and C518 within the singly CHE-9-modified tryptic 
peptide were 28% and 72%, respectively. Our in vitro MS analysis above showed that C151 
was modified using T-REX on recombinant Halo-Keap1. Differences in the identitiy of 
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residues modified may be due to different Keap1 conformational states in cellular 
environment—a result consistent with our recent analysis of residue specificity in 
HNEylation.13
As a means to examine functional importance of the two specific residues modified under T-
REX conditions in cells, mutagenesis studies were performed (Table S3). Although the 
modification at C489 represents a low-confidence score (vide supra), we chose to include 
this residue in our functional mutagenesis studies for completeness sake. We found that the 
single mutants (C613S, and C489S), as well as the double mutant (C613S/C489S) were still 
alkylated by CHE 9 in cells during T-REX targeting (Figure S11a). Although the basal 
levels of ARE are affected by mutation, the mutants remained largely responsive to targeted 
electrophilic modification by CHE 9 with efficiencies similar to wild type, both in terms of 
stabilizing Nrf2 protein (Figure S11b) and in ARE activation (Figure S11c). Furthermore, 
the fact that under non-induced conditions, mutation of C613 and C489 affected the 
unstimulated steady-state levels of Nrf2 (Figure S11c) indicates that these residues are 
important for Keap1 funcitonal integrity. This statment is supported by our previous work 
and that of others examining the consequences of point mutations at C151 and C288—
C151S/C288S also affects unstimulated Nrf2 levels;11b,11h,13 and the mutants are still 
HNEylated upon T-REX targeting.13 Accordingly, there is no reason to assume that 
alkylation of the newly found CHE 9-modified residues in the present study—C613 and 
C489—would not affect Nrf2 steady-state levels. Indeed, both C613 and C489 of 
recombinant human Keap1 have reportedly been modified by overlapping sets of 
electrophiles in vitro.11e Our data showed that C613S and C489S mutants are able to 
respond to CHE 9 under T-REX targeted conditions (Figure S11b and S11c), thereby 
indicating that other residues on Keap1 are also CHE 9-sensitive in cells. These data are 
altogether consistent with our conclusions elsewhere within this present study or in previous 
work.13
Evaluating the Extent of Keap1 LDE Modifcations under T-REX conditions in comparison 
with whole-cell LDE flooding
Gel-based analysis—Using T-REX in cells, ~25% delivery efficiency of CHE 9 was 
achieved (Table 1 entry 9, and Figure S2d). As shown in Eq 1, the calculation of this ~ 25% 
delivery efficiency took into consideration the remaining caged precursor Ht-Pre-CHE 22 on 
Halo post 20-min light exposure in cells (approximately 1/4th of total caged precursor 
molecules remained on Halo post illumination due to incomplete uncaging in cells under the 
low-energy light conditions, Figure S2d). Therefore, the percentage of Keap1 molecules 
modified by CHE 9 under T-REX conditions was ~19% (i.e., 25% × 3/4th). To estimate the 
percentage of Keap1 molecules modified under whole-cell LDE sitmulation, we designed 
the following experiment. One set of cells ectopically expressing Halo-Keap1 was treated 
with Ht-Pre-CHE 22. The Cy5 signal from this sample post cell lysis and Click coupling 
conditions provided us with the reference signal intensity that equates to one equivalent of 
CHE-alkyne 9 stoichiometrically labeled to Halo-Keap1 fusion protein. This reference point 
is made possible because 1:1 covalent binding between HaloTag and the caged precursor 
molecule is achieved under our experimental conditions12. To another set of cells 
ectopically expressing Halo-Keap1, direct CHE 9 treatment (25 μM, 20 min) followed by 
Lin et al. Page 12













cell lysis, Click coupling, and in-gel fluorescence analysis was applied. Comparison 
between the Cy5 signal intensities between these two samples showed the extent of LDE 
labeling under global conditions was ~1.2-fold higher than if Keap1 were to be labled 
stoichiometrically (Figure 11). Importantly, this observation implies that the total amount of 
CHE 9 reacted with Keap1 under whole-cell flooding conditions (25 μM CHE 9, 20 min) is 
~6-fold higher that that achieved under T-REX conditions (Figure S2d), and yet the former 
method provides no additional benefit in terms of antioxidant response pathway activation 
(Figure 9, 10, and S5).
MS-based analysis—We also further analyzed the LC-MS/MS data of CHE 9 
modifications in cells under T-REX and global treatment. The crude estimations of the 
extents of modifications were made using the peak integration method. Briefly, ions (m/z) 
corresponding to the CHE 9-modified peptides and the corresponding non-modified peptides 
were extracted from total-ion chromatograms (TICs) and the peaks were integrated using 
Analyst 1.1 and normalized to the total area under the peaks representing the modified and 
the non-modified peptides. The percentage modifications were 15% for C613 (under T-
REX), and 3% for C513/C518, and 2% for C273 (under whole-cell CHE 9 flooding).
Data interpretations and implications—Notably, upon comparing these two 
independent procedures (i.e., in-gel fluorescence analysis and ion peak integration method), 
the percentage Keap1 modified (15%) for the C613 residue under T-REX conditions was 
within the range of ~19% modification derived from in-gel-fluorescence-based analysis 
discussed above. This observation implies that under T-REX conditions, a significant 
fraction of the released enone was delivered to one particular Cys residue (C613), and that 
no significant loss of CHE modification occurred under analytical conditions. However, 
since our downstream pathway analysis and functional mutagenesis studies showed that the 
magnitude of pathway activation by T-REX method was not dependent upon this specific 
Cys (Figure S11), the results suggest that other Cys residues within Keap1 can compensate 
for the lack of C613—a result that is consistent with functional redundancy displayed by 
multiple Cys residues discussed elsewhere in this manuscript.
Under whole-cell CHE 9 stimulation, the ion peak integration method detected only two 
residues modified (C513/518, and C273) and both within 2–3% modifications. Our simplest 
interpretation for the low percentage modifications is that because Keap1 is a promiscuous 
sensor, the model predicts all Cys residues of Keap1 are likely available to react with a 
reactive LDE present in excess. Indeed, various reports have collectively shown that 26 
Cys’s out of 27 Cys residues-bearing human Keap1 are modified upon global exposure to a 
range of reactive electrophiles.11 Thus, under whole-cell flooding, average percentage of 
Keap1 molecules modified that we deduced from in-gel fluorescence assay data would be 
4.4% (i.e., 120 % / 27) since the labeling is 1.2-fold (or 120%) of the reference Cy5 signal 
intensity (Figure 11). The 4.4% was largely similar to the 2–3% modifications calculated 
from peak integration above for the modifications at C513/518 and C273 under global CHE 
9 treatment. Given such a low modification percentage, the chemical complexity of LDE 
modification of Cys’s and the number of possible adducts, many of the Cys’s modified 
under global LDE flooding conditions are likely below the limit of detection. The residues 
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that were detected could be marginally more kinetically competent than other Cys’s, form 
adducts with higher stability to analytical processing, yield peptides with greater ionization 
properties, or simply more readily detectable above background noise. Although integrated 
ionization values are subject to various biases due to differential ionization properties of the 
modified vs. unmodified fragments, the agreement of these results with our previous results 
and our newest observations in this work suggests that the confidence of our interpretations 
is reasonably high.
DISCUSSION
Gleaning a quantitative understanding of how cell signaling pathways function to deliver the 
most robust physiologic responses remains attractive for developing targeted therapies,27a 
engineering new signaling circuits,27b and establishing new biochemical regulatory 
paradigms.27c One of the major hurdles in modern cellular biochemisry is to map how 
specific chemical signal inputs, such as covalent protein modification of an intracellular 
signaling target, are directly linked to specific biologic signal outputs, such as transcriptional 
response.28 In the field of redox-dependent cell signaling, these challenges are significant 
because: (1) redox-mediator signals are highly reactive and diffusible and once exposed to 
the entire cell are able to modify multiple signaling targets simultaneously;4a,4c (2) unlike 
conventional protein modifications that act as chemical signals—such as glycosylation, and 
phosphorylation, redox-linked modifications largely occur without enzyme assistance; and 
(3) unlike typical small-molecule covalent modifiers such as phosphoryl donors and glycans, 
the diffusible small-molecule redox-modulator signals are intrinsically highly reactive and 
cause stress-related cellular damage when generated uncontrollably.1,3,7
Our laboratory has recently introduced a new idea of redox-linked chemical perturbations 
that can be executed in a target-protein-specific and temporally controlled manner in living 
cells,12 thereby eliminating multi-sensing–multi-response outputs, such as oxidative stress-
related phenotypes. Beyond the initial proof of concept demonstrated with a well-known 
endogenous chemical signal inducer (HNE 1),13 the scope, mechanistic basis, and generality 
of the new chemical biology platform—termed “targetable reactive electrophiles and 
oxidants”, or T-REX—were unknown. In this manuscript, we addressed all of these 
concerns. Furthermore, we transformed the newly introduced T-REX idea into a 
generalizable platform with which we can gain important mechanistic insights into how the 
inducers of different chemical structure and reactivity influence the magnitude of target-
specific signal amplification downstream.
The in vitro kinetic experiments on time-dependent alkylation of recombinant human Keap1 
with three structurally and electronically discrete electrophiles HNE 1, dHNE 3 and CHE 9 
showed that although the progress curves were overall different, the initial alkylation rates 
were similar (Figure 5). Subsequent interrogations into the identity of Keap1 Cys residues 
modified by the different electrophiles showed that HNE 1 labeled many more cysteines 
than CHE 9. These data together are most consistent with Keap1 having a similar maximal 
rate of alkylation with many different electrophiles but the number of Cys’s able to interact 
productively is different for different electrophiles. Such a model would account for the 
difference in alkylation progress curves observed for HNE 1 vs. CHE 9 because as the 
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reaction progressed the reactive sites would be relatively constant for HNE 1 (promiscuous 
modifier) but would diminish for CHE 9 (a more specific modifier).
Subsequent assessment of T-REX-assisted LDE delivery efficiencies to Keap1 in cells 
showed that across various enals and enones featuring diverse small-molecule 
electrophilicity and conformational preference, the delivery efficiencies remained largely 
comparable (Table 1, Figure 6 and S2). Given the percentage of labeling we observed, 
significant differences in the extent of modifications between CHE 9 and more reactive 
enones would be expected unless an encounter complex was formed post photoliberation. 
Indeed, the fact that the delivery efficiency of 4-dehydroxy enal dHNE 3 to Keap1 in cells 
was not appreciably different from 4-hydroxylated variants (1, 4–6), further supports that T-
REX capacity on targeting LDEs to Keap1 in cells was not largely influenced by intrinsic 
electrophilicity of the reactive signals. This result was also expected based on the outcome 
of the in vitro kinetic analysis, which showed similar initial rates of alkylation across HNE 
1, dHNE 3, and CHE 9 (Figure 5). Taken together, replicating T-REX under non-targetable 
conditions in which Halo and Keap1 proteins were seperately expressed also showed no 
detectable alkylation of Keap1 in cells (Figure 7, S3, and S4), an outcome consistent with 
the formation of an initial encounter complex model. Any electrophilic signals diffusing 
beyond the Keap1 microenvironment are most likely captured by GSH present in high (~10 
mM) concentrations.24
Lipid-derived Michael acceptor electrophiles constitute an important class of reactive small-
molecule cues in redox-linked signal transduction.1,3,4 The most recent decade has 
witnessed mounting evidence that linear enals/enones and prostaglandins regulate 
cytoprotective responses through covalent modifications of specific sensor proteins.1,3,4,8,21 
Synthetic Michael acceptor pharmacophores such as CDDOs5c,d and BG-125a,b have also 
recently gained popularity for their therapeutic benefit in upregulating drug-relevant 
response such as Nrf2–ARE signaling. Although Keap1 modification is one of the principal 
mechanisms by which Nrf2–ARE axis is activated (Figure 8),9-11 quantitating the extent of 
modifications—especially establishing linkage between the upstream target- and signal-
specific alkylation to the degree of downstream signaling—is not possible under whole-cell 
LDE flooding. For instance, > 700 cysteines have been profiled as HNE-sensitive targets 
among ~1,000 cysteines assayed from soluble fractions of HNE-treated human proteomes.4a 
Importantly, it has also been unclear whether modest structural variations within small-
molecule inducers significantly perturb the downstream ARE-driven gene activation.1c,4a 
Previous structure–activity relationship studies of limited classes of Nrf2–ARE inducers 
have led to non-harmonious conclusions presumably because many of these reactive 
diffusible inducers also modify multiple redox-sensitive targets beyond Keap1.11,14,15 
Although permeability and stability, among other factors, may also play roles in muddying 
the waters, many of the upstream Nrf2 regulators, such as PKC, PI3K, ERK, p38 MAPK, 
PERK, etc., are also reportedly redox-sensitive in addition to Keap1 and thought to play 
complex roles in executing Nrf2–ARE response (Figure 2, inset).10,11a,e Thus interpretation 
of the data in the realms of redox-dependent signaling derived from global small-molecule 
inducer treatment necessitates utmost caution.
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Our recent pilot study discovered that T-REX-assisted targeted HNEylation on Keap1 alone 
is able to recapitulate Nrf2 stabilization and ARE upregulation achieved by whole-cell HNE 
bathing.13 Our current data with Ht-Pre-dHNE 12, Ht-Pre-DE 21, Ht-Pre-CHE 22, and Ht-
Pre-CPE 23 (Table 1, and Figure 6 and S2) substantiate the previous finding. The virtually 
indistinguishable extent of Nrf2 upregulation (Figure 9 and S5) and ARE activation (Figure 
10) that we now observed from alkylating Keap1 with different Michael acceptors of varied 
chemical properties gave us a second level of insights into the Keap1-selective electrophile 
response mechanisms. The comparable delivery efficiencies we quantitated above (Table 1) 
alongside the Nrf2–ARE upregulation data (Figure 8 and S5) together imply that the 
downstream response is likely controlled by alkylation events instead of specific LDE 
identity. Although Keap1 reacts with diverse LDEs at different overall rates—different 
overall reaction progress curves observed across three distinct LDEs (Figure 5), our cell-
based data involving targeted delivery of a structurally diverse array of LDEs demonstrates 
that Keap1 will respond similarly to a similar modest level of modifications that importantly 
results in similar magnitudes of pathway activation. These data imply that Keap1 is 
remarkably insensitive to steric and electronic perturbations over a broad range of Michael 
acceptor inducers studied. The results strongly indicate that Keap1 has broad-ranging 
electrophile sensing ability. Such data presumably reflect the role of Keap1 as a guardian of 
the cell that has evolved to respond to various reactive stimuli,14b and suggest that Keap1 is 
thus optimally tuned for its complex physiologic sensing role of various LDEs.
Interestingly, in the case of CPE 10, comparison with global electrophile flooding showed 
that T-REX is able to prompt signaling response, whereas multi-hit scenarios from whole-
cell CPE 10 treatment did not afford measurable Nrf2–ARE response under otherwise 
identical conditions (Figure 9b–c and S5b–c). This observation was in spite of the fact that 
CPE 10 was still able to cause cytotoxicity from whole-cell treatement (Figure S7) and able 
to permeate and alkylate Keap1 (Figure S9) within 1 h treatment period. The minimal 
response observed at 4 h was nullified at 18 h (Figure S10a). Given the promiscuous nature 
of cyclopentenone-based LDEs including CPE 10, we interpret this result to indicate that 
off-target effects are able to suppress the modest ARE activation observed initially. This 
interpretation is also backed up the fact that the magnitude of T-REX-assisted ARE 
upregulation for all LDEs studied is at least as high, and in the case of HNE 1, CHE 9, and 
CPE 10, higher than the whole-cell LDE flooding. We conclude that targeted drug design 
toward Keap1-specific small-molecule modifiers may prove fruitful in activating the 
therapeutically beneficial Nrf2–ARE signaling axis, while circumventing non-desirable off-
target modifications and associated cytoxicity. Interestingly, it is striking that global 
treatment with LDE such as CHE 9 leads to such a large excess of CHE 9 modification of 
Keap1 over T-REX conditions (~6 fold) (Figure 11 and S2d), and yet there is no added 
bonus in activating Nrf2–ARE (Figure 9, 10, and S5). This result further testifies to the fact 
that global treatment conditions, although useful representatives of oxidative stress, are 
unlikely to recapitulate endogenous signaling processes well. Instead, uncontrolled bolus 
dosing likely leads to unintended conseqeunces that cannot be easily parsed.
Three independent sets of evidence give credence to the fact that our results are not due to 
artifacts of protein overexpression. (1) Targeted alkylation and pathway activation 
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capabilities were both ablated in the non-fused system in which HaloTag and Keap1 were 
both overexpressed, but separately (Figure 7, S3, S4, and S8). (2) The magnitudes of whole-
cell stimulated ARE upregulation were the same between native cells and cells 
overexpressing target proteins of interest (Figure S12). (3) Ht-Pre-ONE 11 bearing reactive 
enone labeled the entire lysate; yet the Halo-Keap1 was not the band with the highest 
intensity (Figure 6b).
In summary, T-REX approach recapitulates perturbation of a single signaling target with an 
array of reactive electrophiles in basal concentrations against the backdrop of an 
unperturbed proteome. In this way, the method enables the functional mapping of a specific 
chemical signal input on specific intracellular targets to the magnitude of signaling output. 
Our initial pilot tests on targeted HNEylation in cells show the generality with respect to two 
different targets of differential redox sensitivity—Keap1 and PTEN proteins,12 and 
capability of single-target HNEylation in low-stoichiometry in eliciting physiologic 
response.13 The study here (1) established a broader conceptual framework underlying T-
REX targeted delivery concept, (2) shed initial mechanistic insights into the basis of the 
unique T-REX chemical biology method, and (3) highlighted a generalizable T-REX 
toolbox with which we can quantitatively link the upstream target- and signal-specific 
redox-linked perturbations to the strength of pathway activation. The proof of concept was 
exemplified using the validated drug target Nrf2–ARE pathway. When juxtaposed with the 
conventional whole-cell electrophile flooding that led to non-specific alkylation (Figure 6b), 
T-REX strategy, which allows delivery efficiency to be quantitated, is likely a better 
representative of the responsiveness of individual signaling targets to specific modifications 
in their discrete cellular microenvironments in which hydrogen-bonding interactions, and the 
redox status, etc., at a given instant remain largely unperturbed.
It could be argued that for instance, the position of the HaloTag and resulting conformation 
of the fusion protein may bias T-REX to modify select Cys residues that are less frequently 
alkylated by LDE than in the endogenous signaling settings. However, similar levels of 
responses achieved between T-REX and whole-cell stimulation indicate that T-REX is able 
to elicit physiologically relevant signaling that unlikely stems from targeted modifications of 
non-functionally relevant cysteines. In the specific case with human Keap1, there is clearly a 
large degree of functional redundancy within the 27 Cys residues in eliciting electrophile 
signaling. The fact that HaloTagging is non-invasive to Keap1 functional properties,13 
subcellular localization patterns,12 and Nrf2 binding13 further attest to the unimpeding 
nature of HaloTagging and make T-REX a powerful tool to mimic endogenous LDE 
modifications on demand. Although polypharmacological benefits of small molecules are 
appreciated,29 this model is unlikely applicable to reactive species such as HNE which 
irreversibly modifies >700 targets in soluble cellular fractions alone.4a Given this level of 
complexity, it is inherently challenging to quantitatively dissect the consequences of each 
physiologic modification event. T-REX occupies a privileged niche in this regard.
The caged precursors in T-REX were also non-cytoxic (Figure S13). By contrast, global 
treatment with reactive LDEs depletes cell viability as expected (Figure S7). The ability to 
forge a mechanistic link between chemical-signal-specific modifications upstream and 
target-specific signal propagation downstream had not been easily attainable using whole-
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cell electrophile flooding approaches that are non-discriminate, thereby (de)activating many 
pathways simultaneously, or nullifying some phenotypic signaling responses. The 
generalizable T-REX-targeted delivery idea presents new opportunities toward quantitative 
understanding of the functional consequences of modest modifications on specific 
intracellular signaling targets. New levels of fundamental insights into individual LDE-
specific signaling provide a deeper perspective on how these redox-linked signaling 
subsystems execute their optimum physiologic responses in cells.
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ABBREVIATIONS
ARE antioxidant response element
Keap1 Kelch-like ECH-associating protein
Nrf2 nuclear factor-erythroid 2 p45-related factor 2
PTEN phosphatase and tensin homolog deleted on chromosome 10
T-REX targetable reactive electrophiles and oxidants
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(a) The generalizable T-REX (targetable reactive electrophiles and oxidants) approach 
selectively delivers a reactive signaling electrophile of choice to specific redox-sensor 
protein of interest (POI) at a precise time in live cells. Photocaged precursor (pink sphere) is 
covalently linked to HaloTag fused to POI. Low-energy light activation (365 nm, 0.6 
mW/cm2) liberates the desired reactive signal in stoichiometric amount to the 
microenvironment of the POI enabling targeted modification. The spatiotemproally precise 
modification upstream in turn enables quantitative evaluation of single- and target-specific 
response downstream. (b) Energy minimized model of Halo (PDB: 1BN6) with covalently 
bound caged precursor Ht-Pre-CHE 22 showed the caged motif is solvent exposed. Inset 
exemplifies covalent conjugation of 22 to the active site Asp residue on Halo.
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T-REX electrophile toolbox enables assessment of downstream signaling strength triggered 
by target-specific delivery of specific bioactive LDEs (1–10) to specific proteins in cells 
(e.g., Keap1) at a precise time. Inset: The simplified model for Nrf2–ARE pathway. The 
downstream phenotypic responses—Nrf2 stabilization and ARE upregulation—are observed 
from whole-cell LDE flooding. Electrophilic modifications of various upstream redox-
sensitive targets, including Keap1, PTEN, Akt, GSK3, PKC, etc., have been implicated to 
play roles in modulating Nrf2–ARE signaling. Using T-REX, this study directly probes the 
Nrf2–ARE signaling strength selectively elicited by LDE-signal-specific and Keap1-protein-
specific electrophilic modifications in an otherwise unmodified proteome.
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Synthetic strategies for the construction of T-REX electrophile toolbox. (a) The Williamson 
ether synthesis approach. (b) The Mitsunobu approach. See also Scheme S2–S10. All 
compounds are racemic where applicable.
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Light-activatable release efficiencies of HNE 1 and HHE 4 from (a) 17 and (b) 13 covalently 
bound to HaloTag in solution, respectively. See also Figure S1 and Table S1.
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(a) Representative in-gel fluorescence data for the time-dependent alkylation of recombinant 
human His6-Keap1 with 1, 3, and 9. (b) Quantitation of the data in (a) (n = 2) as progress 
curve plots. Inset shows the first 10 min. The “normalized fluorescence” was derived by first 
calculating the ratio of Cy5 : Coomassie signals for each time point, and normalizing the 
resultant values to the respective mean of the last three time points for each LDE.
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(a) Representative data for T-REX-assisted Keap1-specific electrophilic adduction (a) vs. 
whole-cell electrophile flooding (b). (a) Live HEK-293 cells stably expressing Halo-Keap1 
were treated with 25 μM 13 and 23, and the excess washed out. After 20-min light exposure, 
cells were lysed, and the lysate was treated with TEV-protease (separating Halo and Keap1), 
followed by Cy5 click assay reagents. Band a, Halo–Keap1 (104 kDa), b, Keap1 (70 kDa, 
post TEV cleavage), c, Halo (33 kDa). Dark gel is the fluorescence gel of the Coomassie-
stained PVDF membrane on the right. Independent duplicates are shown for light-activated 
TEV-treated samples. “M” indicates the ladder lane. Insets show western blot. See also 
Figure S2, Table 1, and Eq. 1. (b) Whole-cell HNE 1 (25 μM) treatment target non-
specifically. Ht-Pre-ONE 11 reacts before uncaging.
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The mechanistic basis of T-REX platform supports proximity-induced reactivity concept 
within the “target–signal encounter complex”. In-cell T-REX experiment in which Halo and 
Keap1 were not fused failed to deliver electrophile DE 8 to Keap1 using Ht-Pre-DE 21 and 
subsequent illumination (Lane 2 and 3, independent duplicates). By contrast, successful 
targeted delivery was achieved when Halo and Keap1 were fused (Lane 4 and also see Figre 
S2b). Schematic representations for each Lane are shown on the left. DE adduction of 
Keap1 (post TEV-protease cleavage) was observed (band b on gel) as expected in Lane 4. 
Western blot data and coomassie-stained PVDF were also shown. Bands a, b, and c 
correspond to GFP-Keap1 (103 kDa), Keap1 (70 kDa, post TEV-cleavage), and GFP-Halo 
(60 kDa), respectively. “M” indicates the ladder lane. Inset shows reference to the 
schematics. Rabbit polyclonal anti-GFP primary antibody (sc-8334) was used to probe GFP-
Halo protein. All forms of proteins containing Keap1 were probed by mouse monoclonal 
anti-Keap1 primary antibody (Ab119403). See also Figure S3 and S4 for analogous data sets 
with non-GFP-fulsed Keap1.
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Two independent readouts for quantitating the downstream signaling strength selectively 
elicited by target- and signal-specific electrophilic modification of a specific upstream target 
in cells. T-REX-assisted temporally controlled Keap1-specific modifications resulted in 
blockage of Nrf2 degradation. Accumulating Nrf2 (assessed by western blot) consequently 
enabled ARE activation (assessed by ARE-luciferase assay).
Lin et al. Page 28














The upregulation of Nrf2 protein expression levels elicited by T-REX-assisted Keap1-
specific electrophilic modification in HEK-293 cells expressing Halo-Keap1 and Nrf2. See 
also Figure S5. (a) Representative western blot data from T-REX conditions in comparison 
with Ht-caged precursor treatment alone (i.e., no light). (b) Quantitation of data in (a, c) and 
in Figure S5a–b. (c) Representative western blot data (left) and corresponding quantitation 
(right) from T-REX conditions in comparison with whole-cell electrophile (25 μM) soaking. 
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Error bars designate S.D. over 3 independent biological replicates. Nrf2 levels were assessed 
after 18 h incubation period post 20 min light exposure. Vehicle, DMSO.
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Reporter gene assay data on ARE upregulation in HEK-293 cells stably expressing Halo-
Keap1 and transiently expressing Nrf2 alongside ARE-inducible firefly luciferase and 
constitutive Renilla luciferase. For each LDE, the magnitude of ARE induction is compared 
between T-REX conditions and whole-cell electrophile (25 μM) flooding. Vehicle, DMSO. 
See also Figure S6–S7 and S13 for titration of ARE response and cell viability analyses. 
Error bars designate S.D. over 3 independent biological replicates. The ARE response was 
analyzed after 18 h incubation period post 20-min light exposure.
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Representative data from in-gel fluorescence analysis evaluating the extent of Keap1 
modifications under whole-cell LDE flooding. Signal from samples designated as “Ht-Pre-
CHE 22 alone“ equates to 1 equiv of CHE-alkyne 9 stoichiometrically labeled to Halo-
Keap1. See discussion in Text. The data in each case originate from three independent 
biological replicates. (a) “Ht-Pre-CHE 22 alone“ designates live HEK-293 cells transiently 
expressing Halo-Keap1 treated with Ht-Pre-CHE 22 alone without exposure to light (see SI 
for details), followed by cell lysis and Click coupling to Cy5 azide. “CHE 9 
flooding“ designates whole-cell CHE 9 treatment (25 μM, 20 min), followed by cell lysis 
and Click coupling with Cy5 azide. The corresponding Coomassie stained gel is shown on 
the left. (b) Remaining lysate samples from experiment in (a) were subjected to Click 
coupling for in-gel fluorescence analysis followed by western blot using antibodies to Keap1 
and GAPDH (loading control). See also Figure S2d.
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Error range is S.D. (n = 6). See also Figure 6 and S2.
c
Not determined (see discussion in text).
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